ERNA — Ernexa Therapeutics Share News
0.000.00%
Last trade - 00:00NASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:38 AM
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Ernexa Therapeutics Inc - May Offer Up To $50 Million Of Securities - SEC Filing
Brief: Ernexa Therapeutics Announces Successful Pre-Ind FDA Meeting
Brief: Ernexa Therapeutics Announces Oral Presentation At The 67Th American Society Of Hematology
Brief: Cellipont Bioservices And Ernexa Therapeutics Enter Cell Therapy Manufacturing Partnership To Advance Erna-101 Toward Clinical Trials In Ovarian Cancer
Brief: Ernexa Therapeutics Provides Update On Operational Excellence And Performance
Brief: Ernexa Therapeutics Expands Advisory Board As It Prepares For Clinical Development
Brief: Ernexa Therapeutics Secures $6 Million In Second Closing Under Securities Purchase Agreement
Brief: Ernexa Therapeutics Announces 1-For-15 Reverse Stock Split
Brief: Ernexa Therapeutics Inc Files Prospectus For Resale Of 10.4 Million Shares Of Common Stock By Selling Stockholder- SEC Filing
Brief: Eterna Therapeutics Inc - Receives Nasdaq Notice For Minimum Bid Price Non-Compliance